Baystate Wealth Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $4.49M | Sell |
28,657
-502
| -2% | -$77K | 0.33% | 32 |
|
|
2023
Q3 | $4.54M | Buy |
29,159
+679
| +2% | +$112K | 0.37% | 32 |
|
|
2023
Q2 | $4.71M | Buy |
28,480
+627
| +2% | +$101K | 0.39% | 33 |
|
|
2023
Q1 | $4.32M | Sell |
27,853
-262
| -0.9% | -$42.3K | 0.38% | 30 |
|
|
2022
Q4 | $4.97M | Buy |
28,115
+1,568
| +6% | +$271K | 0.45% | 29 |
|
|
2022
Q3 | $4.34M | Sell |
26,547
-2,559
| -9% | -$433K | 0.45% | 25 |
|
|
2022
Q2 | $5.17M | Buy |
29,106
+730
| +3% | +$130K | 0.5% | 25 |
|
|
2022
Q1 | $5.03M | Sell |
28,376
-261
| -0.9% | -$44.4K | 0.44% | 25 |
|
|
2021
Q4 | $4.9M | Buy |
28,637
+1,262
| +5% | +$207K | 0.44% | 25 |
|
|
2021
Q3 | $4.42M | Sell |
27,375
-463
| -2% | -$79K | 0.44% | 24 |
|
|
2021
Q2 | $4.59M | Buy |
27,838
+443
| +2% | +$73.3K | 0.45% | 26 |
|
|
2021
Q1 | $4.5M | Buy |
27,395
+1,589
| +6% | +$257K | 0.48% | 24 |
|
|
2020
Q4 | $4.06M | Sell |
25,806
-2,578
| -9% | -$380K | 0.46% | 26 |
|
|
2020
Q3 | $4.23M | Sell |
28,384
-1,590
| -5% | -$235K | 0.5% | 23 |
|
|
2020
Q2 | $4.21M | Buy |
29,974
+848
| +3% | +$124K | 0.49% | 24 |
|
|
2020
Q1 | $3.82M | Sell |
29,126
-664
| -2% | -$94.2K | 0.5% | 20 |
|
|
2019
Q4 | $4.35M | Buy |
29,790
+616
| +2% | +$83.6K | 0.53% | 22 |
|
|
2019
Q3 | $3.77M | Sell |
29,174
-469
| -2% | -$61.8K | 0.5% | 18 |
|
|
2019
Q2 | $4.13M | Buy |
29,643
+372
| +1% | +$51.5K | 0.54% | 18 |
|
|
2019
Q1 | $4.08M | Buy |
29,271
+240
| +0.8% | +$32.1K | 0.54% | 17 |
|
|
2018
Q4 | $3.79M | Sell |
29,031
-688
| -2% | -$96K | 0.55% | 15 |
|
|
2018
Q3 | $4.09M | Buy |
29,719
+62
| +0.2% | +$8.24K | 0.72% | 13 |
|
|
2018
Q2 | $3.74M | Sell |
29,657
-614
| -2% | -$76.6K | 0.56% | 13 |
|
|
2018
Q1 | $3.84M | Buy |
30,271
+1,967
| +7% | +$266K | 0.58% | 14 |
|
|
2017
Q4 | $4.19M | Buy |
28,304
+8
| +0% | +$1.11K | 0.62% | 14 |
|
|
2017
Q3 | $3.78M | Buy |
28,296
+477
| +2% | +$63.2K | 0.63% | 14 |
|
|
2017
Q2 | $3.68M | Buy |
27,819
+141
| +0.5% | +$18K | 0.66% | 12 |
|
|
2017
Q1 | $3.47M | Buy |
27,678
+285
| +1% | +$34K | 0.67% | 13 |
|
|
2016
Q4 | $3.17M | Buy |
27,393
+2,288
| +9% | +$264K | 0.63% | 13 |
|
|
2016
Q3 | $2.97M | Buy |
25,105
+847
| +3% | +$103K | 0.64% | 11 |
|
|
2016
Q2 | $2.94M | Sell |
24,258
-72
| -0.3% | -$8.18K | 0.66% | 12 |
|
|
2016
Q1 | $2.63M | Sell |
24,330
-218
| -0.9% | -$22.6K | 0.57% | 13 |
|
|
2015
Q4 | $2.52M | Sell |
24,548
-5,758
| -19% | -$579K | 0.54% | 13 |
|
|
2015
Q3 | $2.83M | Buy |
30,306
+7,363
| +32% | +$712K | 0.74% | 12 |
|
|
2015
Q2 | $2.24M | Buy |
22,943
+15,007
| +189% | +$1.5M | 0.6% | 13 |
|
|
2015
Q1 | $798K | Sell |
7,936
-4,151
| -34% | -$422K | 0.22% | 23 |
|
|
2014
Q4 | $1.26M | Sell |
12,087
-2,588
| -18% | -$273K | 0.4% | 20 |
|
|
2014
Q3 | $1.56M | Buy |
14,675
+10,631
| +263% | +$1.1M | 0.5% | 16 |
|
|
2014
Q2 | $423K | Buy |
4,044
+1,483
| +58% | +$150K | 0.14% | 33 |
|
|
2014
Q1 | $252K | Buy |
+2,561
| New | +$237K | 0.09% | 38 |
|
|
2013
Q3 | – | Sell |
-1,878
| Closed | -$161K | – | 133 |
|
|
2013
Q2 | $161K | Buy |
+1,878
| New | +$159K | 0.08% | 42 |
|
Other funds holding JNJ
Baystate Wealth Management's JNJ Position: Q4 2023 in Review
Baystate Wealth Management reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q4 2023, selling an estimated $77K and leaving 28,657 shares worth $4.49M. The position accounts for 0.33% of the portfolio, ranked #32.
Baystate Wealth Management first reported a position in JNJ in Q2 2013 and has held it in 41 quarters since. The position peaked at $5.17M in Q2 2022. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.
- Baystate Wealth Management held 28,657 shares of Johnson & Johnson worth $4.49M as of Q4 2023.
- Baystate Wealth Management sold 502 Johnson & Johnson shares in Q4 2023, an estimated $77K.
- Johnson & Johnson made up 0.33% of Baystate Wealth Management's portfolio in Q4 2023, its #32 holding.
- Baystate Wealth Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 41 quarters since.
- Baystate Wealth Management's Johnson & Johnson position peaked at $5.17M in Q2 2022.
- 3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.
Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.